Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · IEX Real-Time Price · USD
12.29
+2.04 (19.90%)
At close: Apr 24, 2024, 4:00 PM
12.00
-0.29 (-2.36%)
After-hours: Apr 24, 2024, 4:09 PM EDT
Cidara Therapeutics Market Cap
Cidara Therapeutics has a market cap or net worth of $56.06 million as of April 24, 2024. Its market cap has decreased by -44.76% in one year.
Market Cap
56.06M
Enterprise Value
21.63M
1-Year Change
-44.76%
Ranking
Category
Stock Price
$12.29
Market Cap Chart
Since April 15, 2015, Cidara Therapeutics's market cap has decreased from $203.10M to $56.06M, a decrease of -72.40%. That is a compound annual growth rate of -13.29%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 46.70M | -0.43% |
Apr 22, 2024 | 46.90M | -23.86% |
Apr 19, 2024 | 61.60M | -5.67% |
Apr 18, 2024 | 65.30M | - |
Apr 17, 2024 | 65.30M | -1.06% |
Apr 16, 2024 | 66.00M | -11.53% |
Apr 15, 2024 | 74.60M | 1.77% |
Apr 12, 2024 | 73.30M | -6.15% |
Apr 11, 2024 | 78.10M | -6.13% |
Apr 10, 2024 | 83.20M | 5.18% |
Apr 9, 2024 | 79.10M | -18.29% |
Apr 8, 2024 | 96.80M | -7.72% |
Apr 5, 2024 | 104.90M | 7.37% |
Apr 4, 2024 | 97.70M | 2.84% |
Apr 3, 2024 | 95.00M | -1.86% |
Apr 2, 2024 | 96.80M | 10.63% |
Apr 1, 2024 | 87.50M | 5.17% |
Mar 28, 2024 | 83.20M | 9.33% |
Mar 27, 2024 | 76.10M | 13.75% |
Mar 26, 2024 | 66.90M | -0.89% |
Mar 25, 2024 | 67.50M | -3.98% |
Mar 22, 2024 | 70.30M | -3.17% |
Mar 21, 2024 | 72.60M | 5.22% |
Mar 20, 2024 | 69.00M | 6.81% |
Mar 19, 2024 | 64.60M | 2.87% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 707.71B |
Novo Nordisk | 558.37B |
UnitedHealth Group | 447.52B |
Johnson & Johnson | 360.83B |
Merck & Co. | 321.16B |
AbbVie | 299.08B |
AstraZeneca | 219.78B |
Thermo Fisher | 219.24B |